{'fraction_non_alphanumeric': 0.03210175651120533, 'fraction_numerical': 0.047244094488188976, 'mean_word_length': 4.921146953405018, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Relationship between the quantity of treatments and the incidence of spina bifida in Brazil

Background: Spina bifida is the second leading cause of motor disability in childhood. Therefore, it’s important to know if the therapeutic offer for spina bifida is fulfilling its demand. Objectives: To evaluate the relationship between the number of treatments and the incidence of spina bifida in Brazil, between 2016 and 2019. Design and Setting: Descriptive, retrospective study, with secondary data collected in the Hospital Information System of SUS (SIH / SUS) and the Information System of Live Births (SINASC), between 2016 and 2019, in Brazil. Methods: Variables used: frequency of spina bifida by live births and quantity of treatments. Results: In 2016, the frequency of spina bifida by live births was 746 and the number of procedures for treating the disease was 360, resulting in a 0.48 ratio between the treatment quantity and the affected live births. In 2017, the frequency was 711 and the procedure quantity was 337, with a 0.47 proportion. In 2018, the frequency was 726, the procedure quantity 294, with a 0.4 proportion. In 2019, the frequency decreased to 694, with 288 procedures, and a 0.41 proportion. In total, there were 2,877 live births with spina bifida and 1,300 hospital procedures, with a proportion of 0.45. Conclusions: The study shows a clear disparity between the frequency of spina bifida and the procedure quantity for this condition. In addition, the number of procedures was decreased, without a proportional declination in the disease incidence, indicating a need for greater public investment for such treatments.